Tilray Brands (TSX:TLRY) FCF Margin %: -12.36% (As of Feb. 2026)

What is Tilray Brands FCF Margin %?

Tilray Brands TSX:TLRY -3.65% 59 FCF Margin % is -12.36% as of Feb. 2026. GuruFocus rates TSX:TLRY with a GF Score™ of 59/100 and a GF Value™ of C$17.50 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, Tilray Brands ranks worse than 71.92% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tilray Brands's Free Cash Flow for the three months ended in Feb. 2026 was C$-35 Mil. Tilray Brands's Revenue for the three months ended in Feb. 2026 was C$282 Mil. Therefore, Tilray Brands's FCF Margin % for the quarter that ended in Feb. 2026 was -12.36%.

As of today, Tilray Brands's current FCF Yield % is -13.68%.

The historical rank and industry rank for Tilray Brands's FCF Margin % or its related term are showing as below:

TSX:TLRY' s FCF Margin % Range Over the Past 10 Years
Min: -602.28 Med: -41.42 Max: -2.06
Current: -8.59

During the past 13 years, the highest FCF Margin % of Tilray Brands was -2.06%. The lowest was -602.28%. And the median was -41.42%.

TSX:TLRY's FCF Margin % is ranked worse than
71.92% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs TSX:TLRY: -8.59

Tilray Brands FCF Margin % Related Terms

Tilray Brands FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tilray Brands's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tilray Brands FCF Margin % Chart

Tilray Brands Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

May25

FCF Margin %

Get a 7-Day Free Trial

-16.29

-33.63

-2.06

-7.62

-15.53

Tilray Brands Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
FCF Margin %	Get a 7-Day Free Trial															-10.86	-8.52	-5.19	-8.38	-12.36

TSX:TLRY vs IRWD, BIOA, ESPR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tilray Brands FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's FCF Margin % falls into.

Save Embed

59GF Score

Tilray Brands Inc TSX:TLRY

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Tilray Brands FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tilray Brands's FCF Margin for the fiscal year that ended in May. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: May. 2025 )	/	Revenue (A: May. 2025 )
	=	-176.826	/	1138.909
	=	-15.53 %

Tilray Brands's FCF Margin for the quarter that ended in Feb. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Feb. 2026 )	/	Revenue (Q: Feb. 2026 )
	=	-34.885	/	282.148
	=	-12.36 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -12.36% mean?

Tilray Brands (TSX:TLRY) has a FCF Margin % of -12.36% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #689 out of 958 companies in the Drug Manufacturers industry, placing it in the top 71.9%.

Is Tilray Brands' FCF Margin % too high?

Tilray Brands' current FCF Margin % is -12.36%. Based on the distribution chart, Tilray Brands ranks #689 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tilray Brands has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Tilray Brands' FCF Margin % compare to IRWD and BIOA?

According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #689 out of 958 companies for FCF Margin %. This places Tilray Brands in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Drug Manufacturers company?

The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current FCF Margin % is -12.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Tilray Brands stock overvalued right now?

Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.50, compared to a current price of C$6.34 — trading 63.8% below its estimated fair value. The current FCF Margin % is -12.36%. Tilray Brands' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current FCF Margin % is -12.36% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tilray Brands (TSX:TLRY) Overvalued in 2026?

Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued. The current stock price of C$6.34 is trading 63.8% below its estimated GF Value™ of C$17.50. GuruFocus considers Tilray Brands to be Possible Value Trap.

Key valuation signals for TSX:TLRY:

FCF Margin %: -12.36%
GF Value™: C$17.50 vs. price of C$6.34 (63.8% below fair value)
GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tilray Brands Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies IRWD BIOA ESPR AQST AMPH ETON EBS EOLS PCRX ELTP XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges TLRY:USA 2HQ0:Germany TLR2:Austria

Address 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4

Website https://www.tilray.com

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

59GF Score

Get the complete analysis for TSX:TLRY

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$6.34

Price

C$17.50

GF Value

View TSX:TLRY Analysis

See FCF Margin % data for all stocks →